€144.90
0.89% today
Frankfurt, Nov 26, 01:14 pm CET
ISIN
NL0012044747
Symbol
RDC
Index

Redcare Pharmacy Stock price

€146.20
-3.80 2.53% 1M
+34.80 31.24% 6M
+15.20 11.60% YTD
+19.05 14.98% 1Y
-4.50 2.99% 3Y
+109.50 298.37% 5Y
+117.70 412.98% 10Y
Frankfurt, Closing price Mon, Nov 25 2024
+0.70 0.48%
ISIN
NL0012044747
Symbol
RDC
Index
Sector

Key metrics

Market capitalization €2.93b
Enterprise Value €2.99b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 145.96
EV/Sales (TTM) EV/Sales 1.34
P/S ratio (TTM) P/S ratio 1.31
P/B ratio (TTM) P/B ratio 5.79
Revenue growth (TTM) Revenue growth 39.58%
Revenue (TTM) Revenue €2.23b
EBIT (operating result TTM) EBIT €-39.46m
Free Cash Flow (TTM) Free Cash Flow €20.49m
Cash position €209.90m
EPS (TTM) EPS €-1.23
P/E forward negative
P/S forward 1.23
EV/Sales forward 1.25
Show more

Is Redcare Pharmacy a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Redcare Pharmacy Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Redcare Pharmacy forecast:

9x Buy
69%
3x Hold
23%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Redcare Pharmacy forecast:

Buy
69%
Hold
23%
Sell
8%

Financial data from Redcare Pharmacy

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,227 2,227
40% 40%
100%
- Direct Costs 1,779 1,779
44% 44%
80%
448 448
24% 24%
20%
- Selling and Administrative Expenses 418 418
57% 57%
19%
- Research and Development Expense - -
-
-
30 30
69% 69%
1%
- Depreciation and Amortization 69 69
39% 39%
3%
EBIT (Operating Income) EBIT -39 -39
189% 189%
-2%
Net Profit -25 -25
51% 51%
-1%

In millions EUR.

Don't miss a Thing! We will send you all news about Redcare Pharmacy directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Redcare Pharmacy Stock News

AD HOC NEWS
19 days ago
Der seit Wochen starke Lauf der Aktien von Redcare Pharmacy NL0012044747 hat sich am Freitag nach einer positiven Analystenstudie beschleunigt.
AD HOC NEWS
19 days ago
Der gute Lauf der Aktien von Redcare Pharmacy NL0012044747 hat sich am Freitag mit einem Hoch seit Dezember 2021 fortgesetzt.
EQS
21 days ago
Sevenum, die Niederlande, 5. November 2024. Redcare Pharmacy hat heute die endgültigen Umsatz- und Ergebniszahlen für das dritte Quartal veröffentlicht. Der Konzernumsatz für die ersten neun Monate des Jahres belief sich auf EUR 1,7 Mrd., was einer Steigerung von 33,8% gegenüber dem Vorjahr entsp...
More Redcare Pharmacy News

Company Profile

Shop Apotheke Europe NV engages in the provision of medication and pharmacy-related beauty and care products. It operates through the DACH and International geographical segments. The DACH segment sells prescription medicine, prescription-free pharmaceuticals, and beauty and personal care products, and functional food products to individual customers located in the German, the Austrian, and the Swiss market. The International segment trades pharmaceutical products outside European market. The company was founded by Stephan Weber and Marc Fischer in 2001 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Olaf Heinrich
Employees 2,075
Founded 2001
Website www.redcare-pharmacy.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today